About
Dr. Lambl is a research-focused company dedicated to making current medical evidence more accessible and understandable. Our focus is on synthesizing peer-reviewed literature from PubMed related to knee osteoarthritis and its treatment options.
The company is named after Vilém Dušan Lambl, a 19th-century physician and researcher known for his early description of Giardia lamblia and the cardiac structures now referred to as Lambl's excrescences. His work reflects a tradition of careful observation and curiosity-driven medical research — principles that continue to guide our approach today.
Because clinical outcomes and therapeutic considerations can vary significantly with age, our summaries are structured into three distinct groups: under 30, 31–60, and over 60. This approach aims to reflect meaningful differences in patient populations and improve the relevance of the information provided.
All summaries are generated from abstracts published within the past 12 months and are manually reviewed and updated on a regular basis. Our goal is to present concise, structured insights that support informed reading of the scientific landscape — without replacing professional medical judgment.
Dr. Lambl operates solely as a research-driven company and educational project. We do not provide medical advice, clinical recommendations, or direct patient services.